Quince Therapeutics Balance Sheet (2018-2026)

Reported Financials

Quince Therapeutics Quarterly Balance Sheet

Periods 34 quarters

Latest Jun 2026

Quince Therapeutics reported total assets of $124.00M and total liabilities of $159.32M for the quarter ended Jun 2026, up 5.8% year over year. This balance sheet covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	62.21M	69.72M	67.56M	46.93M	31.81M	44.58M	46.71M	22.65M	21.63M	20.75M	21.81M	7.89M	2.68M	6.21M	7.77M	16.83M	6.45M	5.81M	18.16M	115.98M
Short-term InvestmentsInvestments (Current)	52.21M	37.08M	23.96M	47.74M	62.53M	45.60M	43.49M	64.92M	61.59M	54.31M	46.01M	51.56M	45.17M	34.57M	23.83M	17.88M	19.84M	11.94M
Cash & Current Investments	114.41M	106.80M	91.52M	94.66M	94.34M	90.18M	90.20M	87.57M	83.23M	75.06M	67.82M	59.45M	47.85M	40.78M	31.60M	34.71M	26.29M	17.75M	18.20M	116.00M
Receivables - NetNet Receivables									0.50M
Receivables									0.50M
Prepaid Assets	5.02M	4.87M	4.83M	4.71M	3.93M	3.57M	2.29M	0.98M	1.45M	2.38M	2.62M	3.99M	3.87M	3.25M	2.23M	2.64M	2.91M	5.14M	7.42M	7.43M
Current Assets	119.43M	111.67M	96.35M	99.37M	98.28M	93.75M	92.49M	88.55M	85.17M	77.44M	70.44M	63.44M	51.72M	44.04M	33.83M	37.35M	29.20M	22.90M	25.58M	123.41M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.30M	0.26M	0.23M	0.36M	0.38M	0.39M	0.01M	0.01M	0.01M	0.23M	0.23M	0.25M	0.21M	0.32M	0.45M	0.57M	0.62M	0.60M	0.55M	0.51M
Long-Term Investments	26.14M	19.93M	19.20M	11.03M	5.00M	3.58M	0.50M
Goodwill				0.83M						17.63M	17.25M
Intangibles				5.90M	5.90M	5.90M				63.67M	62.25M	61.79M	64.53M	60.05M	62.37M	67.57M	67.73M	67.82M
Goodwill & Intangibles				6.73M	5.90M	5.90M				81.30M	79.50M	61.79M	64.53M	60.05M	62.37M	67.57M	67.73M	67.82M
Other Non-Current Assets	0.19M	0.19M	0.03M	0.05M	0.02M					8.54M	8.47M	8.80M	9.51M	9.58M	9.95M	11.22M	11.87M	1.76M	0.08M	0.08M
Non-Current Assets	27.99M	21.56M	19.78M	18.49M	11.50M	10.16M	0.83M	0.29M	0.21M	90.46M	88.85M	71.39M	74.80M	70.44M	73.26M	79.87M	80.70M	70.63M	1.04M	0.58M
Assets	147.42M	133.23M	116.13M	117.86M	109.78M	103.91M	93.32M	88.84M	85.39M	167.90M	159.29M	134.83M	126.52M	114.48M	107.09M	117.21M	109.90M	93.52M	26.62M	124.00M
Liabilities
Current Liabilities
Accounts Payables	2.88M	4.91M	3.73M	1.87M	1.18M	0.57M	1.65M	0.35M	0.41M	2.03M	2.07M	2.41M	1.62M	2.90M	3.01M	1.76M	3.40M	2.22M	5.39M	4.64M
Payables	2.88M	4.91M	3.73M	1.87M	1.18M	0.57M	1.65M	0.35M	0.41M	2.03M	2.07M	2.41M	1.62M	2.90M	3.01M	1.76M	3.40M	2.22M	5.39M	4.64M
Accumulated Expenses	11.27M	9.31M	5.98M	4.08M	3.76M	2.50M	1.46M	1.60M	1.84M	3.44M	3.02M	2.92M	3.80M	4.38M	5.35M	5.71M	5.12M	10.61M	3.38M	3.86M
Other Accumulated Expenses	7.25M	7.11M	3.49M	0.18M	0.80M	0.50M	0.06M	0.09M	0.15M	0.56M	0.86M			1.03M		2.53M	2.10M	6.97M	1.75M	0.72M
Short term Debt																	17.52M	18.03M
Total Current Liabilities	14.15M	14.22M	9.71M	5.95M	4.95M	3.07M	3.12M	1.95M	2.25M	9.57M	9.84M	10.32M	5.43M	7.28M	8.36M	7.47M	26.04M	43.23M	8.77M	8.50M
Non-Current Liabilities
Capital Leases				0.04M	0.02M
Preferred Stock Liabilities
Minority Interest																				143.81M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax				0.25M	0.25M	0.25M				5.30M	5.18M	5.17M	5.38M	4.96M	5.17M	5.60M	5.59M
Operating Leases	0.61M	0.42M	0.04M	0.10M	0.03M					0.32M	0.39M	0.45M	0.45M	0.39M	0.38M	0.39M	0.36M	0.33M	0.29M
Other Non-Current Liabilities										111.90M	56.10M	120.55M	110.22M	57.38M	117.95M	75.04M	76.84M	51.96M	1.20M	6.29M
Total Non-Current Liabilities						3.32M				-29.08M	29.01M	-32.69M	-28.63M	26.96M	-29.44M	30.44M	32.00M	77.28M	9.76M	153.03M
Total Liabilities	14.76M	14.64M	9.75M	6.33M	5.25M	3.32M	3.12M	1.95M	2.25M	82.82M	85.12M	87.86M	81.59M	84.33M	88.51M	105.47M	108.84M	129.24M	10.95M	159.32M
Shareholder's Equity
Total Debt										13.43M	13.52M	13.83M	14.90M		15.27M	16.99M	17.52M	18.03M
Common Equity	132.65M	118.59M	106.38M	111.53M	104.53M	100.59M	90.20M	86.88M	83.13M	85.08M	74.18M	46.97M	44.93M	30.15M	18.58M	11.74M	1.06M	-35.71M	15.67M	-35.32M
Liabilities and Shareholders Equity	147.42M	133.23M	116.13M	117.86M	109.78M	103.91M	93.32M	88.84M	85.39M	167.90M	159.29M	134.83M	126.52M	114.48M	107.09M	117.21M	109.90M	93.52M	26.62M	124.00M
Retained Earnings	-213.20M	-236.60M	-258.24M	-274.80M	-282.73M	-288.26M	-300.51M	-305.40M	-310.80M	-319.64M	-330.80M	-358.52M	-364.01M	-376.47M	-391.50M	-407.60M	-421.00M	-460.45M	-424.54M	-500.03M

Quince Therapeutics Balance Sheet API

Pull Quince Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNCX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "QNCX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=QNCX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

IRulya Therapeutics QNCX Balance Sheet (2018-2026)

Quince Therapeutics Quarterly Balance Sheet

Quince Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password